Subscription banner for an ophthalmic newsletter
FDA Approves Formycon and Klinge’s Biosimilar to Eylea®

Formycon AG and its licensing partner Klinge Biopharma GmbH announced the U.S. Food and Drug Adminis...

read more
FDA Approves Formycon and Klinge’s Biosimilar to Eylea®
July 03, 2024
ENTOD Pharmaceuticals Introduces Novel Eye Drop Preservative System

Mumbai-based ENTOD Pharmaceuticals has unveiled a novel advancement in ophthalmic care with the intr...

read more
ENTOD Pharmaceuticals Introduces Novel Eye Drop Preservative System
July 17, 2024
Ravegza, Lucentis Biosimilar, Granted Marketing Authorization in Saudi Arabia

Formycon AG and MS Pharma announced that their product, Ravegza (FYB201), a biosimilar to Lucentis (...

read more
Ravegza, Lucentis Biosimilar, Granted Marketing Authorization in Saudi Arabia
March 12, 2024
Visionix Unveils VX 610 Automated Fundus Camera for Diabetic Retinopathy Screening

The VX 610 features auto alignment, auto focus, and auto capture, allowing for consistent, high-qual...

read more
Visionix Unveils VX 610 Automated Fundus Camera for Diabetic Retinopathy Screening
August 22, 2024
Haag-Streit Introduces METIS Ophthalmic Microscope System

Haag-Streit has unveiled the METIS Ophthalmic Microscope System, a state-of-the-art innovation desig...

read more
Haag-Streit Introduces METIS Ophthalmic Microscope System
September 03, 2024
Oculus Introduces Pentacam Cornea OCT at ESCRS 2024

This dual imaging technology captures both Scheimpflug and ultra high-resolution OCT images of the c...

read more
Oculus Introduces Pentacam Cornea OCT at ESCRS 2024
September 05, 2024
Lumenis Launches OptiLIFT to Address Lower Lid Laxity and Impaired Blinking

Lumenis Be. Ltd., a global leader in energy-based medical devices for eye care and aesthetics, has a...

read more
Lumenis Launches OptiLIFT to Address Lower Lid Laxity and Impaired Blinking
February 07, 2025
Bausch + Lomb Launches Dry Eye Drug Miebo in the U.S.

Bausch + Lomb has officially launched Miebo (perfluorohexyloctane ophthalmic solution) for the treat...

read more
Bausch + Lomb Launches Dry Eye Drug Miebo in the U.S.
September 13, 2023
Maestro®: The Sinusoidal IOL

VSY Biotechnology introduced the Maestro® Sinusoidal IOL at ESCRS 2024, featuring SVT. This innovati...

read more
Maestro®: The Sinusoidal IOL
September 18, 2024
FCI Ophthalmics Launches EzyPor Polyethylene Orbital Implant in the US

FCI Ophthalmics announced the launch of EzyPor in the United States. EzyPor is a polyethylene orbita...

read more
FCI Ophthalmics Launches EzyPor Polyethylene Orbital Implant in the US
January 10, 2023
More